yttrium radioisotopes has been researched along with Adrenal Cortex Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albano, D; Basile, V; Berruti, A; Bertagna, F; Cosentini, D; Dalla Volta, A; Filice, A; Grisanti, S; Laganà , M; Morandi, A; Rapa, I; Terzolo, M; Tiberio, GMA; Versari, A; Volante, M | 1 |
| Bley, TA; Bluemel, C; Buck, AK; Fassnacht, M; Hahner, S; Heinze, B; Herrmann, K; Kroiss, M; Kropf, S; Lapa, C; Schirbel, A; Wester, HJ | 1 |
2 other study(ies) available for yttrium radioisotopes and Adrenal Cortex Cancer
| Article | Year |
|---|---|
Treatment With 90Y/177Lu-DOTATOC in Patients With Metastatic Adrenocortical Carcinoma Expressing Somatostatin Receptors.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Octreotide; Prognosis; Prospective Studies; Receptors, Somatostatin; Yttrium Radioisotopes | 2020 |
Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Coordination Complexes; Female; Gallium Radioisotopes; Humans; Lutetium; Male; Middle Aged; Patient Selection; Peptides; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Radioisotopes; Radionuclide Imaging; Radiotherapy; Receptors, CXCR4; Yttrium Radioisotopes | 2017 |